“…Gels from low-molecular-weight gelators (LMWGs) are fascinating pseudosolid, viscoelastic soft materials with a variety of different properties , for numerous biomedical applications including drug delivery . LMWGs undergo reversible, hierarchical self-assembly to mostly form one-dimensional aggregates or nanofibers that can further entangle to form a volume spanning self-assembled fibrillar network (SAFIN). , The process can be reversibly triggered by a variety of different stimuli, but most commonly heat, and is driven by the formation of noncovalent interactions such as hydrogen bonding, π–π stacking, and van der Waals and metal–ligand interactions. , Bulk organogels from LMWGs can be easily downsized to aqueous colloidal dispersions of gelled-oil nanoparticles (GNPs) via a two-step process in which emulsified oil droplets are typically generated via a hot emulsification process followed by cooling. – Although GNPs have exhibited the potential for the encapsulation, protection, and delivery of a variety of bioactives with low water solubility (i.e., nile red and efavirenz, rose bengal and hypericine, rhodamine 123, curcumin, , curcuminaldehyde, sunscreen, indomethacin and ketoconazole, metallophthalocyanine, flurbiprofen, β-carotene, coumarin, paclitaxel, , and doxorubicin), they are still relatively seldom used. The commercially available 12-hydroxystearic acid (HSA) is the most commonly used LMWG for GNPs, ,,– ,, and thus the development of new custom LWMGs offers the opportunity to form gels with a wider variety of organic liquids , as well as introduce other interesting properties to trigger different types of stimuli-responsive systems that could enable tunable release characteristics. – …”